Abstract
BackgroundProprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a major development in the prevention of cardiovascular disease (CVD) and is one of the most significant discoveries since the development of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have